Lumosa Therapeutics Market Cap

Lumosa Therapeutics has a market cap or net worth of 37.82 billion as of September 2, 2025. Its market cap has increased by 16.08% in one year.

Market Cap

37.82B

Enterprise Value

36.82B

Revenue

37.25M

Ranking

n/a

PE Ratio

n/a

Stock Price

233.00

Market Cap Chart

Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 37.82B, an increase of 780.57%. That is a compound annual growth rate of 23.93%.

Market Cap History

Date	Market Cap	% Change
Sep 2, 2025	37.82B	-10.43%
Dec 31, 2024	42.22B	274.74%
Dec 29, 2023	11.27B	75.37%
Dec 30, 2022	6.43B	5.04%
Dec 30, 2021	6.12B	17.77%
Dec 31, 2020	5.19B	28.50%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	326.49B
PharmaEssentia	165.47B
Bora Pharmaceuticals Co., LTD.	88.98B
Lotus Pharmaceutical	49.44B
Oneness Biotech	34.15B
Polaris Group	28.93B
Center Laboratories	26.72B
Pegavision	24.38B

Market Cap Rankings